Abstract

BackgroundMT1-MMP is a cell-surface enzyme whose regulation of pro-MMP-2 and ERK activation position it as a key facilitator of ECM remodelling and cell migration. These processes are modulated by endogenous MMP inhibitors, such as RECK, a GPI-anchored protein which has been shown to inhibit both MT1-MMP and MMP-2 activity. Our previous studies have revealed a link between MT1-MMP levels, and pro-MMP-2 and ERK activation in mammalian cells, as well as MT1-MMP and RECK co-localization in Xenopus embryos. We here investigated how modulation of RECK would impact MT1-MMP and MMP-2 levels, as well as ERK signalling in Xenopus A6 cells.ResultsWe used a Morpholino approach to knockdown RECK, plasmid transfection to overexpress RECK, and PI-PLC treatment to shed RECK from the cell surface of Xenopus A6 cells. RECK reduction did not alter pERK or MT1-MMP levels, nor MMP-2 activity as measured by zymography; thus RECK-knockdown cells maintained the ability to remodel the ECM. RECK overexpression and PI-PLC treatment both increased ECM remodelling potential through increased MT1-MMP protein and relative MMP-2 activation levels.ConclusionsRECK changes that reduce the ability of the cell to remodel the ECM (overexpression and cell surface shedding) are compensated for by increases in MT1-MMP, and MMP-2 levels as seen by zymography.

Highlights

  • MT1-matrix metalloproteinases (MMPs) is a cell-surface enzyme whose regulation of pro-MMP-2 and ERK activation position it as a key facilitator of extracellular matrix (ECM) remodelling and cell migration

  • Having confirmed the efficacy of the RECK MO, we examined the levels of MMPs and their activity in A6 cells following RECK knockdown

  • To address if the maintenance of low levels of MMPs is a common mechanism seen in non-mammalian epithelial cells, here we investigate the impact of altered RECK levels in the context of the ECM remodelers MT1MMP and MMP-2, as well as ERK in Xenopus A6 cells

Read more

Summary

Introduction

MT1-MMP is a cell-surface enzyme whose regulation of pro-MMP-2 and ERK activation position it as a key facilitator of ECM remodelling and cell migration These processes are modulated by endogenous MMP inhibitors, such as RECK, a GPI-anchored protein which has been shown to inhibit both MT1-MMP and MMP-2 activity. In mammalian MDA-MB-231 cells, inhibition of pro-MT1-MMP activation elevated global MT1MMP and pERK levels, but decreased MMP-2 levels [12] These mammalian cell studies demonstrated that when MT1-MMP levels are altered, pERK and MMP-2 activation levels alter in different ways depending on treatment. This suggests a mechanism that may involve more molecules than just MT1-MMP in the activation of ERK and pro-MMP-2, with RECK possibly playing an important role. Several other studies have described interactions between RECK and MT1-MMP proteins in vivo and in vitro [15,16,17], with RECK being shown to complex with MT1-MMP at the cell surface to both attenuate its proteolytic activity and modulate its endocytosis from the cell surface [18]

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call